|
Originator
|
Trade Name
|
Drug Name
|
Innovator & Drug Name
Approval & Launch Dates
|
Innovator & Drug Name
Approval & Launch Dates
|
Innovator & Drug Name
Approval & Launch Dates
|
Innovator & Drug Name
Approval & Launch Dates
|
Innovator & Drug Name
Approval & Launch Dates
|
Innovator & Drug Name
Approval & Launch Dates
|
|
Roche
|
Herceptin
|
Trastuzumab
|
Mylan Ogivri
Dec 2017(A) Nov 2019(L)
|
Teva Herzuma
Dec 2018(A) Mar 2019(L)
|
Merck Ontruzant
Jan 2019(A) Apr 2020(L)
|
Pfizer Trazimera
Mar 2019(A) Feb 2020(L)
|
Amgen Kanjinti
Jun 2019(A) Jul 2019(L)
|
|
|
Roche
|
Rituxan
|
Rituximab
|
Teva Truxima
Nov 2018(A) Nov 2019(L)
|
Pfizer Ruxience
Jul 2019(A) Jan 2020(L)
|
Amgen Riabni
Dec 2020(A) Jan 2021(L)
|
Pfizer Trazimera
Mar 2019(A) Feb 2020(L)
|
Amgen Kanjinti
Jun 2019(A) Jul 2019(L)
|
|
|
Roche
|
Avastin
|
Bevacizumab
|
Amgen Mvasi
Sept 2017(A) Jul 2019(L)
|
Pfizer Zirabev
Jun 2019(A) Jan 2020(L)
|
|
|
|
|
|
J & J
|
Remicade
|
Infliximab
|
Pfizer Ixifi
Dec 2014(A)
|
Pfizer Inflectra
Apr 2016(A) Nov 2016(L)
|
Merck Renflexix
Apr 2017(A) Jul 2018(L)
|
Amgen Avsola
Dec 2019(A) Jul 2020(L)
|
|
|
|
AbbVie
|
Humira
|
Adalimumab
Launch Delayed
Until 2023
|
Amgen Amjevita
Sept 2016(A)
|
Boehringer Ingelheim Cyltexo
Aug 2017(A)
|
Merck Hyrimoz
Oct 2018
|
Merck Hadlima
Jul 2019
|
Pfizer Abrilada
Nov 2019
|
Mylan Hulio
Jul 2020
|
|
Amgen
|
Enbrel
|
Etanercept
On-going Litigation
|
Sandoz Erelzi
Aug 2016
|
Samsung Eticovo
Apr 2019
|
|
|
|
|
|
Amgen
|
Epogen
|
Epoetin Alfa
|
Pfizer Retacrit
May 2018(A) Nov 2018(L)
|
|
|
|
|
|
|
Amgen
|
Neupogen
|
Filgrastim
|
Sandoz Zarxio
Mar 2015(A) Sept 2015(L)
|
Pfizer Nivestym
Jul 2018(A) Oct 2018(L)
|
|
|
|
|
|
Amgen
|
Neulasta
|
Pegfilgrastim
|
Mylan Fulphila
Jun 2018(A) Jul 2018(L)
|
Coherus Udenyca
Nov 2018(A) Jan 2019(L)
|
Sandoz Ziextenzo
Nov 2019(A) Nov 2019(L)
|
Pfizer Nyvepria
June 2020(A) Dec 2020(L)
|
|
|
